Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,358 | 796 | 99.8% |
| Education | $28.14 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,130 | 130 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,925 | 107 | $0 (2024) |
| Novo Nordisk Inc | $1,490 | 69 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,182 | 49 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,002 | 52 | $0 (2024) |
| ITI, Inc. | $976.75 | 58 | $0 (2023) |
| Lilly USA, LLC | $770.36 | 27 | $0 (2024) |
| Merck Sharp & Dohme LLC | $769.34 | 40 | $0 (2023) |
| Allergan, Inc. | $681.18 | 42 | $0 (2021) |
| ABBVIE INC. | $658.77 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,726 | 114 | Amgen Inc. ($720.00) |
| 2023 | $2,662 | 108 | Amgen Inc. ($696.85) |
| 2022 | $2,652 | 109 | ITI, Inc. ($429.74) |
| 2021 | $1,848 | 112 | Amgen Inc. ($367.97) |
| 2020 | $1,585 | 86 | AstraZeneca Pharmaceuticals LP ($434.72) |
| 2019 | $1,941 | 70 | AstraZeneca Pharmaceuticals LP ($748.63) |
| 2018 | $2,160 | 84 | AstraZeneca Pharmaceuticals LP ($308.85) |
| 2017 | $2,812 | 118 | Amgen Inc. ($560.63) |
All Payment Transactions
801 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Inflammation | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Gastroenterology | ||||||
| 10/18/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Hematology | ||||||
| 10/16/2024 | Noven Therapeutics, LLC | Secuado (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: CNS Psychiatry | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Gastroenterology | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | PEDIARIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: VACCINES | ||||||
| 10/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.55 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Womens Health | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 794 | 1,838 | $189,524 | $70,066 |
| 2022 | 17 | 694 | 1,456 | $161,750 | $61,307 |
| 2021 | 18 | 606 | 1,177 | $130,742 | $54,206 |
| 2020 | 16 | 463 | 815 | $89,680 | $32,372 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 151 | 538 | $122,664 | $46,986 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $12,250 | $6,306 | 51.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 66 | 159 | $8,586 | $3,919 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 63 | $9,828 | $3,315 | 33.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 28 | $2,800 | $2,000 | 71.4% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 89 | 361 | $9,025 | $1,390 | 15.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 36 | $1,080 | $1,058 | 98.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 57 | 57 | $2,850 | $1,044 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 55 | 85 | $3,060 | $877.69 | 28.7% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 20 | 46 | $1,426 | $659.64 | 46.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 15 | 16 | $1,792 | $655.04 | 36.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 35 | 35 | $1,365 | $640.85 | 46.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 47 | 54 | $6,750 | $508.05 | 7.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 16 | $1,408 | $455.28 | 32.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 35 | $875.00 | $119.35 | 13.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 87 | $870.00 | $67.70 | 7.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 22 | 109 | $1,635 | $41.96 | 2.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 16 | 63 | $1,260 | $21.89 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 471 | $107,388 | $41,714 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $10,290 | $5,447 | 52.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 75 | 129 | $6,966 | $3,323 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 47 | $7,332 | $2,463 | 33.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 18 | 18 | $1,800 | $1,234 | 68.5% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 78 | 283 | $7,075 | $1,098 | 15.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 17 | 21 | $2,100 | $1,030 | 49.1% |
About Dr. Kamrun Naher, M.D
Dr. Kamrun Naher, M.D is a Family Medicine healthcare provider based in Bakersfield, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1578723110.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kamrun Naher, M.D has received a total of $18,386 in payments from pharmaceutical and medical device companies, with $2,726 received in 2024. These payments were reported across 801 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($18,358).
As a Medicare-enrolled provider, Naher has provided services to 2,557 Medicare beneficiaries, totaling 5,286 services with total Medicare billing of $217,951. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bakersfield, CA
- Active Since 06/16/2008
- Last Updated 07/30/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1578723110
Products in Payments
- FARXIGA (Drug) $1,566
- Otezla (Drug) $1,213
- CAPLYTA (Drug) $1,133
- Ozempic (Drug) $742.59
- REXULTI (Drug) $734.15
- EVENITY (Biological) $683.41
- VRAYLAR (Drug) $669.78
- JARDIANCE (Drug) $559.07
- Kerendia (Drug) $535.30
- TRADJENTA (Drug) $482.23
- Repatha (Biological) $449.49
- Aimovig (Biological) $407.19
- BREZTRI (Drug) $378.81
- LINZESS (Drug) $345.91
- AIRSUPRA (Drug) $341.29
- SYMBICORT (Drug) $330.18
- MOUNJARO (Drug) $323.15
- BEXSERO (Biological) $320.26
- Prolia (Biological) $283.28
- BELSOMRA (Drug) $271.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bakersfield
Mrs. Amira Ayad, M.d, M.D
Family Medicine — Payments: $278,616
Matthew Beare, M.d, M.D
Family Medicine — Payments: $81,707
Tien Nguyen, M.d, M.D
Family Medicine — Payments: $25,013
Neha Chande, M.d., M.h.s, M.D., M.H.S
Family Medicine — Payments: $20,779
John Heidrick, D.o, D.O
Family Medicine — Payments: $20,029
Dr. Ashokkumar Ghadia, M.d, M.D
Family Medicine — Payments: $16,231